ERBB2 and breast cancer: Comprehensive BC assessment includes not only anatomical data, but also important prognostic data, such as the expression of estrogen receptors (ERs) and progesterone receptors (PRs), human epidermal growth factor receptor 2 (HER2), and available gene expression data [6,7,8,9].